Plain-English translation of NCT06738654 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether single-port robot-assisted breast surgery—a newer surgical technique that works through a tiny incision in the armpit—is as safe and effective as traditional open surgery for early breast cancer. The robot-assisted approach aims to remove the cancer while leaving minimal scarring on the breast. Researchers will compare how well both surgical methods work, how quickly patients recover, and how satisfied patients are with their results.
Many patients with early breast cancer want to keep their breast while ensuring the cancer is completely removed, but they're also concerned about scarring and how their breast will look afterward. This trial exists to see whether the new robot-assisted technique can achieve good cancer removal with less visible scarring and faster recovery than traditional surgery.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll have imaging tests (mammogram, ultrasound, and MRI) before surgery, then receive either robot-assisted surgery or traditional open surgery—your choice may depend on cost and equipment availability. After surgery, you'll stay in the hospital while doctors monitor you for complications and manage your pain. You'll have follow-up visits at 28 days, 90 days, and then at 3 years to check for cancer recurrence and assess your recovery, appearance, and quality of life.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China